Latest News
- 2022
- 2021
NuGen M.D. Launches PetJet™ Providing Needle-Free Injections for Domesticated Pets
NuGen M.D. announces that it will be launching a needle-free injection device specifically designed for domesticated household pets.
NuGen Announces Results of its Annual and Special Meeting and Approval of Amendments to Stock Option Plan
NuGen M.D. is pleased to announce that all matters submitted to shareholders for approval as set out in detail in the Company’s management information circular dated May 17, 2022 were approved at the annual and special meeting of the shareholders of the Company held on June 17, 2022.
NuGen M.D. Submits for FDA Emergency Use Authorization Approval for its Needle-Free Injection Systems
NuGen M.D., in collaboration with Unifire, Inc., submitted on June 14th, 2022, an application to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (“EUA”) of NuGen reusable needle-free jet injector (NFJI) systems.
NuGen M.D. Launches New InsuJetTM Brand Store for Direct Purchasing in The European Union (EU)
NuGen Medical Devices Inc. (TSXV: NGMD) (“NuGen” or the “Company”), a leader in needle-free drug delivery, is pleased to announce the launch of a new online brand store for its InsuJetTM needle-free injection device.
Draganfly Inc. to Begin Delivering NuGen Medical Device’s Needle-Free Injection Devices and Insulin to Ukraine Type 1 Diabetics In Urgent Need of Supply
NuGen selected Draganfly Inc. and Coldchain Delivery Systems, Inc. to provide drones and services for the delivery of InsuJet™, insulin, and other crucial medical supplies to Ukraine.
Kin Communications and NuGen M.D. Respond to Diabetes Crisis in Ukraine
Kin Communications has joined forces with NuGen Medical Devices to raise funds in order to purchase insulin to be administered and delivered with NuGen M.D’s needle-free injection device also known as InsuJet™, to Ukrainian diabetics urgently in need of daily insulin injections to stay alive.
NuGen M.D. Announces Middle East Distribution Agreements With Minimum Commitments of Over $2.5 Million for its InsuJet™ Needle-Free Injection Device
NuGen Medical Devices Inc. and Unifire, Inc. are pleased to announce they have entered into a Master Distribution and Marketing Agreement dated March 14 2022, whereas Unifire has been granted exclusive rights to sell NuGen M.D.’s needle-free injection device into various US Government agencies.
NuGen M.D. and Unifire Inc. Announce Partnership to Market and Distribute its Needle-Free Injection Device to United States Government Agencies
NuGen Medical Devices Inc. and Unifire, Inc. are pleased to announce they have entered into a Master Distribution and Marketing Agreement dated March 14 2022, whereas Unifire has been granted exclusive rights to sell NuGen M.D.’s needle-free injection device into various US Government agencies.
NuGen M.D. Announces a $2 Million 5-Year Distribution Agreement with Kuwait JV for its InsuJet™ Needle-Free Injection Device
NuGen Medical Devices is pleased to announce that it has signed a 5-year distribution agreement (the “Agreement”) with Harrington Consultants Limited and its joint venture partner Al Mufid Pharmaceuticals (the “Kuwait Joint Venture” or the “Distributor”).
NuGen Medical Devices Receives Health Canada Approval for its Needle-Free Injection System
First self-administered, needle-free injection system approved by Health Canada gives access to safe, painless, cost-effective, and more sustainable drug delivery
NuGen Announces a $5.8M, 5-Year Distribution Agreement with Khotwa Medical Co. for its InsuJet Needle Free Injection Device and Accessories
NuGen and Khotwa Providing Access to Safe and Effective, Needle Free Injections to a World Plagued with Diabetes TORONTO, Ontario
NuGen MD Announces Head of Global Sales & Strategic Partnerships
TORONTO, November 16, 2021 (Newsfile Corp.) – NuGen Medical Devices Inc. (TSXV: NGMD) (“NuGen MD” or the “Company”), a leader
NuGen MD Commences Trading on the TSX Venture Under Symbol ‘NGMD’ and Provides Investor Relations and Market-Maker Update
TORONTO, November 8, 2021 (Newswire.com) – NuGen Medical Devices Inc. (TSXV: NGMD) (“NuGen MD” or the “Company”), a leader in needle-free
NuGen Announces Expected Trading Resumption on the TSX Venture Exchange
Download PDF TORONTO, November 4, 2021 (Newswire.com) – NuGen Medical Devices Inc. (formerly BuzBuz Capital Corp.) (the “Company”), is pleased